knowledge -WSS

knowledge

author：comprehensive 2025-08-26 10:52:27 - browse：8335

Adobe

More than a year ago, Kaiser Permanente made waves when it said it was creating a new, sprawling entity of nonprofit hospitals and doctors with Geisinger as its first takeover — the latest example of health care companies bulking up in an already highly consolidated industry.

Nothing has happened since then, at least publicly. Geisinger’s 10 hospitals and 1,700 employed physicians are now officially part of the group, known as Risant Health. Kaiser, which is both a health insurance company and a network of providers, said it wants to add at least five to six more health systems by 2028.

Those other organizations are still a mystery. But recent financial reports show a handful of systems that have been on the same shaky trajectory as Geisinger and could find themselves in Kaiser’s crosshairs. Patients and local communities have a lot at stake if their health system gets gobbled up by Kaiser; it’s still unclear how this unique structure will alter costs or quality of care.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： The HPV vaccine prevents cancer in men, too. Why do so few people get it?

hotspot

WSS

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Lawsuit challenges CMS nursing home minimum staffing rule

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Unmasking the 'centricity' illusion in clinical trials

PBM reform efforts get punted in Congress

The world needs the new pandemic treaty

leisure time

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

In Memoriam: Notable people who died in 2023

Guardant Health colon cancer test endorsed by FDA advisory panel

Heart attack and stroke risk calculators need revising

Unmasking the 'centricity' illusion in clinical trials

Psychedelics group wrestles with new pharma identity

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

In age of alternative facts, a scholarly course on calling out crap

The HPV vaccine prevents cancer in men, too. Why do so few people get it?

Medical records are filled with copy

Unmasking the 'centricity' illusion in clinical trials

leisure time

Pharma’s losing bet in New Jersey

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

Stroke rates rising, especially in working

A solution to the after

Alabama IVF ruling threatens families facing fatal genetic disease

Medicare inequities exacerbate Puerto Rico’s health disparities

entertainment

knowledge

hotspot

leisure time